EUVIMEDEUVIMED entdecken
Crossref

Screening of Spider Venom Peptides and Molecular Docking of FLT3 and LCK

Durgesh M Agase

Bulletin of Pure & Applied Sciences- Zoology · 2023

DOI: 10.48165/bpas.2023.42a.1.13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of Pure & Applied Sciences- Zoology, 2023. Verfasst von Durgesh M Agase.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The drawbacks of traditional chemotherapy include its inability to dissolve in water, lack of selectivity, and multidrug resistance. The use of anticancer peptides is a unique therapeutic approach against cancer cells. In this In-silico work, the kinase inhibition activity for both chosen target molecules (Flt3 and Lck protein) was evaluated in order to find a possible anti-leukemic spider venom peptide. Out of the 11 spider venom peptides, Lycosin-I peptide (from Lycosa singoriensis) for Lck and Latarcin 2a peptide (from Lachesana tarabaevi) for Flt3 were suggested as the best lead peptides for the creation of anti-leukemic drugs.

Zitieren

APA

Agase, D. M. (2023). Screening of Spider Venom Peptides and Molecular Docking of FLT3 and LCK. Bulletin of Pure & Applied Sciences- Zoology. https://doi.org/10.48165/bpas.2023.42a.1.13

Vancouver

Agase DM. Screening of Spider Venom Peptides and Molecular Docking of FLT3 and LCK. Bulletin of Pure & Applied Sciences- Zoology. 2023. doi:10.48165/bpas.2023.42a.1.13

BibTeX
@article{Agase2023,
  author = {Agase, Durgesh M},
  title = {Screening of Spider Venom Peptides and Molecular Docking of FLT3 and LCK},
  journal = {Bulletin of Pure & Applied Sciences- Zoology},
  year = {2023},
  doi = {10.48165/bpas.2023.42a.1.13}
}
Kostenlos starten →